← back to search

R. Lepeule

Inserm · FR
Area of research
Epidemiology · Molecular Medicine
Research interest
Research interests include Infective Endocarditis Diagnosis and Management, Antibiotic Resistance in Bacteria, Antimicrobial Resistance in Staphylococcus, and Antibiotics Pharmacokinetics and Efficacy.
h-index
26
citations
3,437
works
143
NIH funding
primary concept
Medicine
email

Recent publications

Cloxacillin versus cefazolin for meticillin-susceptible Staphylococcus aureus bacteraemia (CloCeBa): a prospective, open-label, multicentre, non-inferiority, randomised clinical trial
The Lancet 2025cited by 10position: middledoi
Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial
The Lancet Infectious Diseases 2024cited by 76position: middledoi
Compared Performance of the 2023 Duke–International Society for Cardiovascular Infectious Diseases, 2000 Modified Duke, and 2015 European Society of Cardiology Criteria for the Diagnosis of Infective Endocarditis in a French Multicenter Prospective Cohort
Clinical Infectious Diseases 2024cited by 22position: middledoi
Pharmacokinetic interaction between rifampicin and clindamycin in staphylococcal osteoarticular infections
International Journal of Antimicrobial Agents 2023cited by 15position: middledoi
Novel SARS-CoV-2 Variant Derived from Clade 19B, France
Emerging infectious diseases 2021cited by 25position: middledoi
A 5-day course of oral antibiotics followed by faecal transplantation to eradicate carriage of multidrug-resistant Enterobacteriaceae: a randomized clinical trial
Clinical Microbiology and Infection 2019cited by 173position: middledoi
Carbapenems and alternative β-lactams for the treatment of infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae: What impact on intestinal colonisation resistance?
International Journal of Antimicrobial Agents 2018cited by 61position: middledoi
Experiences and perspectives of implementing antimicrobial stewardship in five French hospitals: a qualitative study
International Journal of Antimicrobial Agents 2018cited by 35position: middledoi
Emergence of Imipenem-Resistant Gram-Negative Bacilli in Intestinal Flora of Intensive Care Patients
Antimicrobial Agents and Chemotherapy 2013cited by 310position: middledoi
French 2010–2011 measles outbreak in adults: report from a Parisian teaching hospital
Clinical Microbiology and Infection 2013cited by 24position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Charles Burdet · Inserm4 papers (2018–2025)Étienne Ruppé · Université Claude Bernard Lyon 12 papers (2013–2018)Michel Wolff · Université Claude Bernard Lyon 12 papers (2013–2025)Jean‐Christophe Lucet · Inserm2 papers (2013–2018)A. Lefort · Institut Pasteur2 papers (2023–2025)Jean‐Winoc Decousser · Université Claude Bernard Lyon 12 papers (2018–2021)François Barbier · Université Claude Bernard Lyon 12 papers (2013–2018)François-Xavier Lescure · Inserm2 papers (2018–2025)Bruno Mourvillier · Université Claude Bernard Lyon 11 papers (2018–2018)Alexandre Soulier · Université Claude Bernard Lyon 11 papers (2021–2021)C. Rioux · Université Claude Bernard Lyon 11 papers (2013–2013) · 1 papers (2013–2013)Y. Yazdanpanah · Université Claude Bernard Lyon 11 papers (2018–2018)Laure Surgers · French Clinical Research Infrastructure Network1 papers (2025–2025) · 1 papers (2018–2018)Xavier Duval · Johns Hopkins Hospital1 papers (2025–2025) · 1 papers (2018–2018) · 1 papers (2023–2023)Yannick Costa · Université Claude Bernard Lyon 11 papers (2021–2021) · 1 papers (2023–2023)